Recruiting Systemic Mastocytosis Studies in Stanford
About Systemic Mastocytosis Clinical Trials in Stanford
Systemic mastocytosis is a rare condition caused by accumulation of abnormal mast cells in the bone marrow, skin, liver, spleen, and GI tract. It can cause allergic reactions, bone pain, and organ damage. Treatment includes targeted therapies, antihistamines, and mast cell stabilizers.
There are currently 1 systemic mastocytosis clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 140 participants. Research is being sponsored by Cogent Biosciences, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Systemic Mastocytosis Clinical Trials in Stanford — FAQ
Are there systemic mastocytosis clinical trials in Stanford?
Yes, there are 1 systemic mastocytosis clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stanford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.
Are clinical trials in Stanford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.
What systemic mastocytosis treatments are being tested?
The 1 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for systemic mastocytosis.
Data updated March 2, 2026 from ClinicalTrials.gov